Infective endocarditis in hypertrophic cardiomyopathy: Prevalence, incidence, and indications for antibiotic prophylaxis

Circulation

Volumn 99, Issue 16, 1999, Pages 2132-2137

  Spirito, Paolo ^a   Rapezzi, Claudio ^b   Bellone, Pietro ^c   Betocchi, Sandro ^d   Autore, Camillo ^e   Conte, Maria Rosa ^f   Bezante, Gian Paolo ^g   Bruzzi, Paolo ^h  

^a GALLIERA HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SANTA CORONA HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f OSPEDALE DEGLI INFERMI   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

Author keywords

Cardiomyopathy; Echocardiography; Hypertrophy

Indexed keywords

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; CHILD; ENTEROCOCCUS FAECALIS; FEMALE; HEART ATRIUM ENLARGEMENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS SANGUINIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033608947     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.16.2132     Document Type: Article

References (30)

1. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA. 1997;277:1794-1801.
2. Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995; 332:38-44.
3. Chagnac A, Rudniki C, Loebel H, Zahavi I. Infectious endocarditis in idiopathic hypertrophic subaortic stenosis: report of three cases and review of the literature. Chest. 1982;81:346-349.
4. Alessandri N, Pannarale G, Del Monte F, Moretti F, Marino B, Reale A. Hypertrophic obstructive cardiomyopathy and infective endocarditis: a report of 7 cases and a review of the literature. Eur Heart J. 1990;11: 1041-1048.
5. Roberts WC, Kishel JC, McIntosh CL, Cannon RO III, Maron BJ. Severe mitral or aortic valve regurgitation, or both, requiring valve replacement for infective endocarditis complicating hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19:365-371.
6. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316:780-789, 844-852.
7. Spirito P, Chiarella F, Carratino L, Zoni-Berisso M, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749-755.
8. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92: 1680-1692.
9. Watkins H, McKenna WJ, Thierfelder L, Suk H, Anan R, O'Donoghue A, Spirito P, Matzumori A, Moravec C, Seidman J, Seidman C. The role of cardiac troponin T and a tropomyosin mutations in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058-1064.
10. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
11. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257.
12. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614.
13. Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani P, Fragola P, Chiarella F, Berisso M, Branzi A, Cannata D, Magnani B, Vecchio C. Prognosis in asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 1994;90: 2743-2747.
14. Jaffe WM, Morgan DE, Pearlman AS, Otto CM. Infective endocarditis. 1983-1988: echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol. 1990;15:1227-1233.
15. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200-209.
16. Spirito P, Maron BJ, Chiarella F, Bellotti P, Tramarin R, Pozzoli M, Vecchio C. Diastolic abnormalities in hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. Circulation. 1985; 72:310-316.
17. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Canliol. 1990;15:1521-1526.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58: 1072-1083.
19. Pollick C, Rakowski H, Wigle ED. Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation. 1984;69:43-49.
20. Sasson Z, Yock PG, Hatle LK, Alderman EL, Popp RL. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1988;11:752-756.
21. Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1992;19:91-99.
22. Wang K, Gobel FL, Gleason DF. Bacterial endocarditis in idiopathic hypertrophie subaortic stenosis. Am Heart J. 1975;89:359-365.
23. Robbins N, Szilagyi G, Tanowitz HB, Luftschein S, Baum SG. Infective endocarditis caused by streptococcus mutans. A complication of idiopathic hypertrophic subaortie stenosis. Arch Intern Med. 1977;137:1171-1174.
24. Pitcher D, Mary D. Listeria monocytogenes endocarditis in hypertrophic cardiomyopathy. Br Med J. 1978;15:961.
25. Greenland P, Murphy GW. Acute valvular insufficiency complicating hypertrophie obstructive cardiomyopathy. Chest. 1979;75:182-183.
26. LeJemtel TH, Factor SM, Koenigsberg M, O'Reilly M, Frater R, Sonnemblick EH. Mural vegetations at the site of endocardial trauma in infective endocarditis complicating idiopathic hypertrophic subaortic stenosis. Am J Cardiol. 1979;44:569-574.
27. Ah Fat LN, Patel BR, Pickens S. Actinobacillus actinomycetemcomitans endocarditis in hypertrophic obstructive cardiomyopathy. J Infect. 1983; 6:81-84.
28. Ovsyshcher IA, Zimlichman R. Infective endocarditis in hypertrophic cardiomyopathy secondary to amiodarone treatment. Chest. 1983;83:833. Letter.
29. Malouf J, Nasrallah A, Daghir I, Harake M, Mufarrij A. Candida tropicalis endocarditis in idiopathic hypertrophic subaortie stenosis. Chest. 1984;86:508. Letter.
30. Stulz P, Zimmerli W, Mihatsch J, Gradel E. Recurrent infective endocarditis in idiopathic hypertrophic subaortic stenosis. Thorac Cardiovasc Surg. 1989;37:99-102.